APO Research
Talk to an analyst

APO RESEARCH · REPORT

Activin-A

Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.

Selected research

Market Outlook & Growth Opportunities

Global Activin-A Market Outlook and Growth Opportunities 2026

31 December 2025194 pages

Choose your research edition.

Industry ResearchActivin-A Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Activin-A Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Activin-A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Activin-A Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Activin-A Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.

Major players in the industry are Merck Millipore, Thermo Fisher Scientific and bio-techne, which accounted for 26.80%, 12.00% and 10.32% of revenue in 2019, respectively. By region, North America has the highest share of income, at 52.22 percent in 2019.

This report provides an overview of the global Activin-A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Activin-A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Activin-A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Activin-A market size, projected growth trends, production technologies, key applications, and end-use industries.

Activin-A Segment by Company

Merck Millipore

Thermo Fisher Scientific

Bio-Techne

StemRD

Prospec

Proteintech Group

Ajinomoto

Enzo Life Sciences

IBL

STEMCELL

Sino Biological

PeproTech

ReproCELL

Activin-A Segment by Type

Activin-A Human

Activin-A Mouse(Rat)

Activin-A Segment by Application

Commercial Research

Academic Research

Activin-A Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Activin-A status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Activin-A market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Activin-A significant trends, drivers, influence factors in global and regions.

6. To analyze Activin-A competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin-A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Activin-A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin-A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Activin-A market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Activin-A industry.

Chapter 3: Detailed analysis of Activin-A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Activin-A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Activin-A in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Activin-A Industry Trends Table 2. Activin-A Industry Drivers Table 3. Activin-A Industry Opportunities and Challenges Table 4. Activin-A Industry Restraints Table 5. Global Activin-A Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Activin-A Revenue Share by Company (2021-2026) Table 7. Global Activin-A Sales Volume by Company (mg) & (2021-2026) Table 8. Global Activin-A Sales Volume Share by Company (2021-2026) Table 9. Global Activin-A Average Price (US$/ug) of Company (2021-2026) Table 10. Global Activin-A Company Ranking, (2024-2026) & (USD Million) Table 11. Global Activin-A Key Company Manufacturing Base & Headquarters Table 12. Global Activin-A Company, Product Type & Application Table 13. Global Activin-A Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Activin-A by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Activin-A Human Table 18. Significant Companies of Activin-A Mouse(Rat) Table 19. Global Activin-A Sales Volume by Type 2021 VS 2025 VS 2032 (mg) Table 20. Global Activin-A Sales Volume by Type (2021-2026) & (mg) Table 21. Global Activin-A Sales Volume by Type (2027-2032) & (mg) Table 22. Global Activin-A Sales Volume Share by Type (2021-2026) Table 23. Global Activin-A Sales Volume Share by Type (2027-2032) Table 24. Global Activin-A Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Activin-A Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Activin-A Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Activin-A Sales Value Share by Type (2021-2026) Table 28. Global Activin-A Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Commercial Research Table 30. Significant Companies of Academic Research Table 31. Global Activin-A Sales Volume by Application 2021 VS 2025 VS 2032 (mg) Table 32. Global Activin-A Sales Volume by Application (2021-2026) & (mg) Table 33. Global Activin-A Sales Volume by Application (2027-2032) & (mg) Table 34. Global Activin-A Sales Volume Share by Application (2021-2026) Table 35. Global Activin-A Sales Volume Share by Application (2027-2032) Table 36. Global Activin-A Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Activin-A Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Activin-A Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Activin-A Sales Value Share by Application (2021-2026) Table 40. Global Activin-A Sales Value Share by Application (2027-2032) Table 41. Global Activin-A Sales by Region: 2021 VS 2025 VS 2032 (mg) Table 42. Global Activin-A Sales by Region (2021-2026) & (mg) Table 43. Global Activin-A Sales Market Share by Region (2021-2026) Table 44. Global Activin-A Sales by Region (2027-2032) & (mg) Table 45. Global Activin-A Sales Market Share by Region (2027-2032) Table 46. Global Activin-A Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Activin-A Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Activin-A Sales Value Share by Region (2021-2026) Table 49. Global Activin-A Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Activin-A Sales Value Share by Region (2027-2032) Table 51. Global Activin-A Market Average Price (US$/ug) by Region (2021-2026) Table 52. Global Activin-A Market Average Price (US$/ug) by Region (2027-2032) Table 53. Global Activin-A Sales by Country: 2021 VS 2025 VS 2032 (mg) Table 54. Global Activin-A Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Activin-A Sales by Country (2021-2026) & (mg) Table 56. Global Activin-A Sales Market Share by Country (2021-2026) Table 57. Global Activin-A Sales by Country (2027-2032) & (mg) Table 58. Global Activin-A Sales Market Share by Country (2027-2032) Table 59. Global Activin-A Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Activin-A Sales Value Market Share by Country (2021-2026) Table 61. Global Activin-A Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Activin-A Sales Value Market Share by Country (2027-2032) Table 63. Merck Millipore Company Information Table 64. Merck Millipore Business Overview Table 65. Merck Millipore Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 66. Merck Millipore Activin-A Product Portfolio Table 67. Merck Millipore Recent Development Table 68. Thermo Fisher Scientific Company Information Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific Activin-A Product Portfolio Table 72. Thermo Fisher Scientific Recent Development Table 73. Bio-Techne Company Information Table 74. Bio-Techne Business Overview Table 75. Bio-Techne Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 76. Bio-Techne Activin-A Product Portfolio Table 77. Bio-Techne Recent Development Table 78. StemRD Company Information Table 79. StemRD Business Overview Table 80. StemRD Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 81. StemRD Activin-A Product Portfolio Table 82. StemRD Recent Development Table 83. Prospec Company Information Table 84. Prospec Business Overview Table 85. Prospec Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 86. Prospec Activin-A Product Portfolio Table 87. Prospec Recent Development Table 88. Proteintech Group Company Information Table 89. Proteintech Group Business Overview Table 90. Proteintech Group Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 91. Proteintech Group Activin-A Product Portfolio Table 92. Proteintech Group Recent Development Table 93. Ajinomoto Company Information Table 94. Ajinomoto Business Overview Table 95. Ajinomoto Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 96. Ajinomoto Activin-A Product Portfolio Table 97. Ajinomoto Recent Development Table 98. Enzo Life Sciences Company Information Table 99. Enzo Life Sciences Business Overview Table 100. Enzo Life Sciences Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 101. Enzo Life Sciences Activin-A Product Portfolio Table 102. Enzo Life Sciences Recent Development Table 103. IBL Company Information Table 104. IBL Business Overview Table 105. IBL Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 106. IBL Activin-A Product Portfolio Table 107. IBL Recent Development Table 108. STEMCELL Company Information Table 109. STEMCELL Business Overview Table 110. STEMCELL Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 111. STEMCELL Activin-A Product Portfolio Table 112. STEMCELL Recent Development Table 113. Sino Biological Company Information Table 114. Sino Biological Business Overview Table 115. Sino Biological Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 116. Sino Biological Activin-A Product Portfolio Table 117. Sino Biological Recent Development Table 118. PeproTech Company Information Table 119. PeproTech Business Overview Table 120. PeproTech Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 121. PeproTech Activin-A Product Portfolio Table 122. PeproTech Recent Development Table 123. ReproCELL Company Information Table 124. ReproCELL Business Overview Table 125. ReproCELL Activin-A Sales (mg), Value (US$ Million), Price (US$/ug) and Gross Margin (2021-2026) Table 126. ReproCELL Activin-A Product Portfolio Table 127. ReproCELL Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Activin-A Distributors List Table 131. Activin-A Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Activin-A Product Image Figure 2. Global Activin-A Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Activin-A Sales Value (2021-2032) & (US$ Million) Figure 4. Global Activin-A Sales (2021-2032) & (mg) Figure 5. Global Activin-A Sales Average Price (US$/ug) & (2021-2032) Figure 6. Global Activin-A Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Activin-A Human Image Figure 10. Activin-A Mouse(Rat) Image Figure 11. Global Activin-A Sales Volume by Type (2021 VS 2025 VS 2032) & (mg) Figure 12. Global Activin-A Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Activin-A Sales Volume Share by Type (2021-2032) Figure 14. Global Activin-A Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Activin-A Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Activin-A Sales Value Share by Type (2021-2032) Figure 17. Commercial Research Image Figure 18. Academic Research Image Figure 19. Global Activin-A Sales Volume by Application (2021 VS 2025 VS 2032) & (mg) Figure 20. Global Activin-A Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Activin-A Sales Volume Share by Application (2021-2032) Figure 22. Global Activin-A Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Activin-A Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Activin-A Sales Value Share by Application (2021-2032) Figure 25. Global Activin-A Sales by Region: 2021 VS 2025 VS 2032 (mg) Figure 26. Global Activin-A Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Activin-A Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Activin-A Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Activin-A Sales Value (2021-2032) & (US$ Million) Figure 30. North America Activin-A Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Activin-A Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Activin-A Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Activin-A Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Activin-A Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Activin-A Sales Value (2021-2032) & (US$ Million) Figure 36. South America Activin-A Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Activin-A Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Activin-A Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Activin-A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Activin-A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Activin-A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Activin-A Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Activin-A Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Activin-A Human
  • Activin-A Mouse(Rat)
Applications
  • Commercial Research
  • Academic Research
Companies covered
  • Merck Millipore
  • Thermo Fisher Scientific
  • Bio-Techne
  • StemRD
  • Prospec
  • Proteintech Group
  • Ajinomoto
  • Enzo Life Sciences
  • IBL
  • STEMCELL
  • Sino Biological
  • PeproTech
  • ReproCELL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Activin-A Sales Value (2021-2032)
  4. 1.2.2 Global Activin-A Sales Volume (2021-2032)
  5. 1.2.3 Global Activin-A Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Activin-A Market Dynamics
  1. 2.1 Activin-A Industry Trends
  2. 2.2 Activin-A Industry Drivers
  3. 2.3 Activin-A Industry Opportunities and Challenges
  4. 2.4 Activin-A Industry Restraints
3 Activin-A Market by Company
  1. 3.1 Global Activin-A Company Revenue Ranking in 2025
  2. 3.2 Global Activin-A Revenue by Company (2021-2026)
  3. 3.3 Global Activin-A Sales Volume by Company (2021-2026)
  4. 3.4 Global Activin-A Average Price by Company (2021-2026)
  5. 3.5 Global Activin-A Company Ranking (2024-2026)
  6. 3.6 Global Activin-A Company Manufacturing Base and Headquarters
  7. 3.7 Global Activin-A Company Product Type and Application
  8. 3.8 Global Activin-A Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Activin-A Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Activin-A Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Activin-A Market by Type
  1. 4.1 Activin-A Type Introduction
  2. 4.1.1 Activin-A Human
  3. 4.1.2 Activin-A Mouse(Rat)
  4. 4.2 Global Activin-A Sales Volume by Type
  5. 4.2.1 Global Activin-A Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Activin-A Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Activin-A Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Activin-A Sales Value by Type
  9. 4.3.1 Global Activin-A Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Activin-A Sales Value by Type (2021-2032)
  11. 4.3.3 Global Activin-A Sales Value Share by Type (2021-2032)
5 Activin-A Market by Application
  1. 5.1 Activin-A Application Introduction
  2. 5.1.1 Commercial Research
  3. 5.1.2 Academic Research
  4. 5.2 Global Activin-A Sales Volume by Application
  5. 5.2.1 Global Activin-A Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Activin-A Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Activin-A Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Activin-A Sales Value by Application
  9. 5.3.1 Global Activin-A Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Activin-A Sales Value by Application (2021-2032)
  11. 5.3.3 Global Activin-A Sales Value Share by Application (2021-2032)
6 Activin-A Regional Sales and Value Analysis
  1. 6.1 Global Activin-A Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Activin-A Sales by Region (2021-2032)
  3. 6.2.1 Global Activin-A Sales by Region: 2021-2026
  4. 6.2.2 Global Activin-A Sales by Region (2027-2032)
  5. 6.3 Global Activin-A Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Activin-A Sales Value by Region (2021-2032)
  7. 6.4.1 Global Activin-A Sales Value by Region: 2021-2026
  8. 6.4.2 Global Activin-A Sales Value by Region (2027-2032)
  9. 6.5 Global Activin-A Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Activin-A Sales Value (2021-2032)
  12. 6.6.2 North America Activin-A Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Activin-A Sales Value (2021-2032)
  15. 6.7.2 Europe Activin-A Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Activin-A Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Activin-A Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Activin-A Sales Value (2021-2032)
  21. 6.9.2 South America Activin-A Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Activin-A Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Activin-A Sales Value Share by Country, 2025 VS 2032
7 Activin-A Country-level Sales and Value Analysis
  1. 7.1 Global Activin-A Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Activin-A Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Activin-A Sales by Country (2021-2032)
  4. 7.3.1 Global Activin-A Sales by Country (2021-2026)
  5. 7.3.2 Global Activin-A Sales by Country (2027-2032)
  6. 7.4 Global Activin-A Sales Value by Country (2021-2032)
  7. 7.4.1 Global Activin-A Sales Value by Country (2021-2026)
  8. 7.4.2 Global Activin-A Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Activin-A Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Activin-A Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Activin-A Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Activin-A Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Activin-A Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Activin-A Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Activin-A Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Activin-A Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Activin-A Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Activin-A Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Activin-A Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Activin-A Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Activin-A Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Activin-A Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Activin-A Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Activin-A Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Activin-A Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Activin-A Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Activin-A Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Activin-A Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Activin-A Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Activin-A Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Activin-A Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Activin-A Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Activin-A Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Activin-A Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Activin-A Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Activin-A Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Activin-A Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Activin-A Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Activin-A Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Activin-A Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Activin-A Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Activin-A Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Activin-A Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Activin-A Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Activin-A Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Activin-A Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Activin-A Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Activin-A Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Activin-A Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Activin-A Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Activin-A Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Activin-A Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Activin-A Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Activin-A Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Activin-A Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Activin-A Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Activin-A Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Activin-A Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Activin-A Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Activin-A Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Activin-A Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Activin-A Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Activin-A Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Activin-A Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Activin-A Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Activin-A Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Activin-A Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Activin-A Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Activin-A Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Activin-A Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Activin-A Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Activin-A Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Activin-A Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Activin-A Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Activin-A Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Activin-A Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Activin-A Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Activin-A Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Activin-A Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Activin-A Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Activin-A Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Activin-A Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Activin-A Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Activin-A Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Activin-A Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Activin-A Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Activin-A Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Activin-A Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Activin-A Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Activin-A Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Activin-A Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Activin-A Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Millipore
  2. 8.1.1 Merck Millipore Company Information
  3. 8.1.2 Merck Millipore Business Overview
  4. 8.1.3 Merck Millipore Activin-A Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Millipore Activin-A Product Portfolio
  6. 8.1.5 Merck Millipore Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Activin-A Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Activin-A Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Bio-Techne
  14. 8.3.1 Bio-Techne Company Information
  15. 8.3.2 Bio-Techne Business Overview
  16. 8.3.3 Bio-Techne Activin-A Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Techne Activin-A Product Portfolio
  18. 8.3.5 Bio-Techne Recent Developments
  19. 8.4 StemRD
  20. 8.4.1 StemRD Company Information
  21. 8.4.2 StemRD Business Overview
  22. 8.4.3 StemRD Activin-A Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 StemRD Activin-A Product Portfolio
  24. 8.4.5 StemRD Recent Developments
  25. 8.5 Prospec
  26. 8.5.1 Prospec Company Information
  27. 8.5.2 Prospec Business Overview
  28. 8.5.3 Prospec Activin-A Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Prospec Activin-A Product Portfolio
  30. 8.5.5 Prospec Recent Developments
  31. 8.6 Proteintech Group
  32. 8.6.1 Proteintech Group Company Information
  33. 8.6.2 Proteintech Group Business Overview
  34. 8.6.3 Proteintech Group Activin-A Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Proteintech Group Activin-A Product Portfolio
  36. 8.6.5 Proteintech Group Recent Developments
  37. 8.7 Ajinomoto
  38. 8.7.1 Ajinomoto Company Information
  39. 8.7.2 Ajinomoto Business Overview
  40. 8.7.3 Ajinomoto Activin-A Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ajinomoto Activin-A Product Portfolio
  42. 8.7.5 Ajinomoto Recent Developments
  43. 8.8 Enzo Life Sciences
  44. 8.8.1 Enzo Life Sciences Company Information
  45. 8.8.2 Enzo Life Sciences Business Overview
  46. 8.8.3 Enzo Life Sciences Activin-A Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Enzo Life Sciences Activin-A Product Portfolio
  48. 8.8.5 Enzo Life Sciences Recent Developments
  49. 8.9 IBL
  50. 8.9.1 IBL Company Information
  51. 8.9.2 IBL Business Overview
  52. 8.9.3 IBL Activin-A Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 IBL Activin-A Product Portfolio
  54. 8.9.5 IBL Recent Developments
  55. 8.10 STEMCELL
  56. 8.10.1 STEMCELL Company Information
  57. 8.10.2 STEMCELL Business Overview
  58. 8.10.3 STEMCELL Activin-A Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 STEMCELL Activin-A Product Portfolio
  60. 8.10.5 STEMCELL Recent Developments
  61. 8.11 Sino Biological
  62. 8.11.1 Sino Biological Company Information
  63. 8.11.2 Sino Biological Business Overview
  64. 8.11.3 Sino Biological Activin-A Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sino Biological Activin-A Product Portfolio
  66. 8.11.5 Sino Biological Recent Developments
  67. 8.12 PeproTech
  68. 8.12.1 PeproTech Company Information
  69. 8.12.2 PeproTech Business Overview
  70. 8.12.3 PeproTech Activin-A Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PeproTech Activin-A Product Portfolio
  72. 8.12.5 PeproTech Recent Developments
  73. 8.13 ReproCELL
  74. 8.13.1 ReproCELL Company Information
  75. 8.13.2 ReproCELL Business Overview
  76. 8.13.3 ReproCELL Activin-A Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ReproCELL Activin-A Product Portfolio
  78. 8.13.5 ReproCELL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Activin-A Value Chain Analysis
  2. 9.1.1 Activin-A Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Activin-A Sales Mode & Process
  6. 9.2 Activin-A Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Activin-A Distributors
  9. 9.2.3 Activin-A Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst